Cohort Study to Evaluate the Relapse Risk Test in Colorectal Cancer

NCT05115786 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-03-23

No results posted yet for this study

Summary

A Retrospective Cohort Study to Evaluate a Multigene assay to assess the recurrence risk of colorectal cancer.

Conditions

Sponsors & Collaborators

  • mProbe Inc.

    collaborator INDUSTRY
  • HBI Solutions Inc.

    lead INDUSTRY

Principal Investigators

  • Junjie Peng, M.D · Shanghai Cancer Hospital, China

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-31
Primary Completion
2024-12-31
Completion
2024-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05115786 on ClinicalTrials.gov